Annual Report 2021

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2021 129 The United Laboratories International Holdings Limited Annual Report 2021 35. DERIVATIVE FINANCIAL INSTRUMENT 2021 2020 RMB’000 RMB’000 Cross currency interest rate swap – liability 5,812 4,573 The Group’s derivative financial instrument represents a cross currency interest rate swap contract for hedging a portion of its foreign exchange risk related to its bank borrowings denominated in foreign currencies. Major terms of the cross currency interest rate swaps are as follows: Year ended 31 December 2021 Notional amount Maturity Exchange rate Pay/Receipt fixed Sell USD44,644,000 6 May 2022 USD1: HKD7.75 2.73% Buy HKD346,000,000 6 May 2022 USD1: HKD7.75 HIBOR+2.35% Sell USD89,288,000 8 November 2022 USD1: HKD7.75 2.73% Buy HKD692,000,000 8 November 2022 USD1: HKD7.75 HIBOR+2.35% Year ended 31 December 2020 Notional amount Maturity Exchange rate Pay/Receipt fixed Sell USD44,644,000 7 May 2021 USD1: HKD7.75 2.73% Buy HKD346,000,000 7 May 2021 USD1: HKD7.75 HIBOR+2.35% Sell USD44,644,000 5 November 2021 USD1: HKD7.75 2.73% Buy HKD346,000,000 5 November 2021 USD1: HKD7.75 HIBOR+2.35% Sell USD44,644,000 6 May 2022 USD1: HKD7.75 2.73% Buy HKD346,000,000 6 May 2022 USD1: HKD7.75 HIBOR+2.35% Sell USD89,288,000 8 November 2022 USD1: HKD7.75 2.73% Buy HKD692,000,000 8 November 2022 USD1: HKD7.75 HIBOR+2.35%